Ampio Pharmaceuticals Inc.’s recent filing unveils that its CFO STOKELY DAN unloaded Company’s shares for reported $40275.0 on Jun 25. In the deal valued at $1.79 per share,22,500 shares were sold. As a result of this transaction, STOKELY DAN now holds 28,315 shares worth roughly $ 5379.85.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
While this happened, ROTH Capital initiated its Ampio Pharmaceuticals Inc. [AMPE] rating to a Buy in a research note published on Tuesday, December 19, 2019; the price target was $4. PT values the company’s stock at a premium of 95.25 to its Tuesday closing price. A number of analysts have revised their coverage, including Aegis Capital’s analysts, who remained covering the stock and in mid March has reiterated a ‘”a Buy”‘ rating for it. Aegis Capital began covering AMPE with a “Buy” recommendation on September 25, 2012.
Price Performance Review of AMPE
On Tuesday, Ampio Pharmaceuticals Inc. [AMEX:AMPE] saw its stock jump 17.28% to $0.19. On the same session, the stock had its day’s lowest price of $0.16, but rose to a high of $0.20. Over the last five days, the stock has lost -14.57%. Ampio Pharmaceuticals Inc. shares have fallen nearly -66.67% since the year began. Nevertheless, the stocks have fallen -89.67% over the past one year. While a 52-week high of $1.92 was reached on 03/24/22, a 52-week low of $0.15 was recorded on 05/25/22. SMA at 50 days reached $0.2375, while 200 days put it at $0.7771. A total of 8.82 million shares were traded, compared to the trading of 4.85 million shares in the previous session.
Levels Of Support And Resistance For AMPE Stock
The 24-hour chart illustrates a support level at 0.1691, which if violated will result in even more drops to 0.1481. On the upside, there is a resistance level at 0.2030. A further resistance level may holdings at 0.2159. The Relative Strength Index (RSI) on the 14-day chart is 46.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0206, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.76%. Stochastics %K at 11.05% indicates the stock is a buying.
How much short interest is there in Ampio Pharmaceuticals Inc.?
A steep rise in short interest was recorded in Ampio Pharmaceuticals Inc. stocks on Apr 28, 2022, growing by 4.52 million shares to a total of 22.86 million shares. Yahoo Finance data shows the prior-month short interest on Mar 30, 2022 was 18.34 million shares. There was a rise of 19.77%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 10.25% of the overall stock float, the days-to-cover ratio (short ratio) rose to 6.16.
Ampio Pharmaceuticals Inc. [AMPE] – Who Are The Largest Shareholders?
In filings from BlackRock Fund Advisors, it is revealed that the company now owns 13,092,136 shares, or roughly 5.76% of the outstanding AMPE shares. In other words, the investor’s shares have risen by 118,993 from its previous 13-F filing of 12973143.0. Additionally, The Vanguard Group, Inc. increased 1.20% of its stake after which the total value it holdings stand at $1,635,771, while SSgA Funds Management, Inc. added 1.97% of its stake to hold $0.63 million in the firm. Over the last quarter, Geode Capital Management LLC sold -162,876 shares of Ampio Pharmaceuticals Inc., while Renaissance Technologies LLC sold -134,531 shares. At present, Willis Investment Counsel, Inc. is holding 2,075,840 shares valued at $0.38 million. Northern Trust Investments, Inc. owned 1,725,267 shares of the company at the time of its most recent 13F filing, worth $0.32 million.
According to FactSet, Ampio Pharmaceuticals Inc.’s share price will average $2.50 in the next year, based on opinions of analysts polled by the firm. This is up nearly 1462.5 percent from its previous closing price of $0.16. Analysts expect Ampio Pharmaceuticals Inc. stock to reach the higher price of $3.00, while the lowest price estimate is $2.00. However, 2 analysts have rated AMPE stock as a Buy in their predictions for 2022.